CTLA4 and cancer: A previous study has shown that the anti-cancer efficacy and immunostimulatory effect of cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) blockade, an immune checkpoint blockade, rely upon different Bacteroides species, such as the Bacteroides thetaiotaomicron and B. fragilis[233].